OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
Kamlesh Bisht, Taro Fukao, Marielle Chiron, et al.
Cancer Medicine (2023) Vol. 12, Iss. 20, pp. 20332-20352
Open Access | Times Cited: 18

Showing 18 citing articles:

Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature
Emiliano Barbieri, Enrica Antonia Martino, Elena Rivolti, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 365-381
Closed Access | Times Cited: 5

Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects
Alberto L. Horenstein, Angelo Corso Faini, Fabio Morandi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts
Mattia D’Agostino, Marina Martello, Lorenzo De Paoli, et al.
Annals of Hematology (2025)
Open Access

Exploring the depths of IgG4: insights into autoimmunity and novel treatments
Selen Ünlü, Blanca G. Sánchez Navarro, Elif Çakan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 775-776
Open Access | Times Cited: 2

Diagnosis of light‑chain deposition disease after renal transplantation: A case report and literature review
Jing Yue, Fang Xu, Ya Zhang, et al.
Experimental and Therapeutic Medicine (2024) Vol. 28, Iss. 3
Open Access | Times Cited: 1

Association of Blood NK Cell Phenotype with the Severity of Liver Fibrosis in Patients with Chronic Viral Hepatitis C with Genotype 1 or 3
В. В. Цуканов, А. А. Савченко, M. A. Cherepnin, et al.
Diagnostics (2024) Vol. 14, Iss. 5, pp. 472-472
Open Access

Novel CD73 Inhibitors for Treating Cancer
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 571-572
Closed Access

Immune and Microbial Signatures Associated with PD-1 Blockade Sensitivity in a Preclinical Model for HPV+ Oropharyngeal Cancer
Jennifer Díaz-Rivera, Michael A. Rodríguez-Rivera, Natalie M. Meléndez-Vázquez, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2065-2065
Open Access

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells
Kathrin Kläsener, Nadja Herrmann, Liliana Håversen, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 10
Open Access

Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy
Alí N. Kamali, Haleh Hamedifar, Michael Eisenhut, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2024) Vol. 12
Open Access

Mechanisms and salvage treatments in patients with multiple myeloma relapsed post-BCMA CAR-T cell therapy
Bingjie Fu, Rui Liu, Gongzhizi Gao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities
Kamlesh Bisht, Aimee Merino, Rob Igarashi, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access

Enhancing complement activation by therapeutic anti-tumor antibodies: Mechanisms, strategies, and engineering approaches
Vitalijs Ovcinnikovs, Karin Dijkman, Gijs G. Zom, et al.
Seminars in Immunology (2024) Vol. 77, pp. 101922-101922
Open Access

Page 1

Scroll to top